Q

Quince Therapeutics
D

QNCX

17.855
USD
-0.49
(-2.64%)
مغلق
حجم التداول
222
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
17,461,529
المقالات
المزيد

العنوان: Quince Therapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.